✦ LIBER ✦

290 EARLY VIROLOGICAL RESPONSE PROFILES WITH TELAPREVIR (T) IN COMBINATION WITH PEGINTERFERON-ALFA-2A (P) AND RIBAVIRIN (R) IN GENOTYPE 1 HCV TREATMENT-NAIVE AND TREATMENT-EXPERIENCED PATIENTS ARE SIMILAR

✍ Scribed by F. Poordad; J.G. McHutchison; M.L. Shiffman; T. Berg; A.J. Muir; M.P. Manns; A.M. Di Bisceglie; N. Terrault; G. Picchio; A. Kwong; L. Bengtsson; S. George; N. Adda

Book ID: 117378376
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 188 KB
Volume: 52
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(10)60292-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

10 RESULTS OF A PROOF OF CONCEPT STUDY (

10 RESULTS OF A PROOF OF CONCEPT STUDY (C210) OF TELAPREVIR MONOTHERAPY AND IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 4 HCV PATIENTS

✍ Y. Benhamou; J. Moussalli; V. Ratziu; P. Lebray; V. Gysen; K. de Backer; A. Ghys 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

56 ON-TREATMENT RESPONSE-GUIDED THERAPY

56 ON-TREATMENT RESPONSE-GUIDED THERAPY WITH TELAPREVIR Q8H OR Q12H COMBINED WITH PEGINTERFERON ALFA-2A OR PEGINTERFERON ALFA-2B AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 1 HEPATITIS C (STUDY C208)

✍ X. Forns; P. Marcellin; P. Ferenci; T. Göser; F. Nevens; G. Carosi; J.P. Drenth; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 55 KB

60 SILEN-C1: SUSTAINED VIROLOGIC RESPONS

60 SILEN-C1: SUSTAINED VIROLOGIC RESPONSE (SVR) AND SAFETY OF BI201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (P/R) IN TREATMENT-NAIVE PATIENTS WITH CHRONIC GENOTYPE 1 HCV INFECTION

✍ M.S. Sulkowski; E. Ceasu; T. Asselah; F.A. Caruntu; J. Lalezari; P. Ferenci; A. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

415 TELAPREVIR IN COMBINATION WITH PEGIN

415 TELAPREVIR IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN INCREASED SUSTAINED VIROLOGIC RESPONSE RATES IN TREATMENT-NAIVE PATIENTS REGARDLESS OF RACE OR ETHNICITY

✍ G.M. Dusheiko; M.W. Fried; R. Reddy; D.R. Nelson; N. Bzowej; N. Adda; C.I. Wrigh 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 173 KB

448 RESPONSE-GUIDED THERAPY WITH BOCEPRE

448 RESPONSE-GUIDED THERAPY WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN REDUCES DURATION IN NAIVE AND PEGINTERFERON ALFA-2B/RIBAVIRIN PREVIOUS-TREATMENT-FAILURE PATIENTS WITH HCV GENOTYPE 1

✍ M.P. Manns; F. Poordad; B.R. Bacon; S. Bruno; R. Esteban; M. Silva; M. Buti; M. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 114 KB

12 HIGH SVR12 WITH 16 WEEKS OF TEGOBUVIR

12 HIGH SVR12 WITH 16 WEEKS OF TEGOBUVIR AND GS-9256 WITH PEGINTERFERON-ALFA 2A AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 1 HCV PATIENTS

✍ D.R. Nelson; E. Lawitz; V. Bain; N. Gitlin; T. Hawkins; P. Marotta; K. Workowski 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 127 KB